Imbria Pharmaceuticals

About:

Imbria Pharmaceuticals is a biotechnology company with locations in San Diego, CA, and Boston, MA.

Website: https://www.imbria.com

Top Investors: RA Capital Management, Sanofi Ventures

Description:

Imbria Pharmaceuticals’ mission is to translate our understanding of cellular metabolism into innovative medicines that improve the lives of patients with limited or inadequate treatment options. The company was founded by doctors and launched by an all doctor executive team motivated by the promise of bringing new therapies to people in need. We are propelled by a deep scientific interest in cellular metabolism and the mitochondria, and are guided by both values and a code of business conduct built upon our commitment to always put the patients, families and communities we serve at the forefront of all that we do.

Total Funding Amount:

$80.9M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Boston, Massachusetts, United States

Founded Date:

2018-01-01

Contact Email:

investorrelations(AT)imbria.com

Founders:

Andrew Levin, David-Alexandre Gros

Number of Employees:

1-10

Last Funding Date:

2020-07-03

IPO Status:

Private

Industries:

© 2025 bioDAO.ai